Vishal Dutta

  • Dr Batra’s plans foray into hair dye  segment

    Dr Batra’s plans foray into hair dye segment

    Dr Batra’s, a multispecialty chain of homeopathy clinics, is bracing for an entry into hair dyes and colours as part of its recent decision to diversify into flourishing segments that will complement growth in its bead-and-butter hair-treatment and skincare treatment business.

    Belgium-Gujarat diamond ties may extend to pharma

    Belgium-Gujarat diamond ties may extend to pharma

    It is not tough to get a Gujarati thali in Antwerp, and Navratri is a known festival in the Belgian city. Back home in Gujarat, Dinesh Navadia, a diamond trader, is as comfortable with Antwerp as he is with his hometown Surat.

    Mylan sells stake in Concord Biotech

    Mylan sells stake in Concord Biotech

    World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.

    Zydus first Indian co to file H1N1 clinical trials

    Zydus first Indian co to file H1N1 clinical trials

    The race among Indian pharma companies engaged in swine flu vaccine development may soon throw up a winner just when the pandemic enters a critical stage with the onset of winter.

    Gujarat gearing up with latest swine-flu vaccine

    Gujarat gearing up with latest swine-flu vaccine

    While Gujarat’s chief minister Narendra Modi is down with Swine Flu, the state will see a swine flu vaccine being developed using the most advanced technology available so far.

  • No blogs yet have been written by the author, we’re sure the author will contribute one soon

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service